INFLUVAC TETRA (Viatris Pty Ltd)
Product name
INFLUVAC TETRA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
196 (255 working days)
Active ingredients
influenza virus haemagglutinin
Registration type
EOI
Indication
For the prevention of influenza caused by influenza virus, types A and B.
For full details regarding recommendations for influenza vaccination, please refer to the relevant National Immunisation Guidelines.
INFLUVAC TETRA (suspension for injection) is now also indicated in adults and children from 6 months of age and older.